Ataxia Treatment Market Size

Ataxia Treatment Market size is projected to grow at substantial growth rate during the forecast period i.e., between 2024-2036. The growth of the market can be attributed to the increasing prevalence of ataxia around the world, and growing number of incidences of autoimmune diseases such as sclerosis, sarcoidosis and celiac disease. According to the United States Library of Medicine, ataxia occurs in 1 in 40,000 to 1000,000 people around the world. In the United States alone, 150,000 people are suffering from this disease. Along with these, rising alcohol and drug usage can lead to the deficiency of vitamin B-12, vitamin E and thiamine. The lack of these nutrients in the body is considered to be a major cause of ataxia, which in turn is expected to drive the growth of the market in the near future. Furthermore, rising technological advancements in the healthcare sector in developed and developing nations, coupled with escalating introduction of new treatment techniques is projected to offer lucrative opportunities for market growth in the forthcoming years.